TY  - JOUR
AU  - López-Gómez, Carlos
AU  - Oliver-Martos, Begoña
AU  - Pinto-Medel, María-Jesús
AU  - Suardiaz, Margarita
AU  - Reyes-Garrido, Virginia
AU  - Urbaneja, Patricia
AU  - Fernández, Óscar
AU  - Leyva, Laura
PY  - 2015
DO  - 10.1136/jnnp-2014-309932
UR  - http://hdl.handle.net/10668/9683
T2  - Journal of neurology, neurosurgery, and psychiatry
AB  - We aimed to assess the effects of interferon β (IFNβ) treatment on the expression of the splice variants of the Tumour necrosis factor-Related Apoptosis Inducing Ligand (TRAIL) and its receptors in different cell subpopulations (CD14+, CD4+ and CD8+)...
LA  - en
KW  - INTERFERON
KW  - MULTIPLE SCLEROSIS
KW  - Adult
KW  - Biomarkers
KW  - CD4-Positive T-Lymphocytes
KW  - Female
KW  - Gene Expression
KW  - Humans
KW  - Interferon-beta
KW  - Jurkat Cells
KW  - Kinetics
KW  - Male
KW  - Middle Aged
KW  - Monocytes
KW  - Multiple Sclerosis
KW  - Polymerase Chain Reaction
KW  - Protein Isoforms
KW  - RNA, Messenger
KW  - Receptors, TNF-Related Apoptosis-Inducing Ligand
KW  - T-Lymphocytes
KW  - TNF-Related Apoptosis-Inducing Ligand
TI  - TRAIL and TRAIL receptors splice variants during long-term interferon β treatment of patients with multiple sclerosis: evaluation as biomarkers for therapeutic response.
TY  - research article
VL  - 87
ER  -